Okacet

Quick links to important sections

Okacet

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Okacet

Quick Facts

Property Description
Active ingredient Cetirizine Hydrochloride
Form Tablet, Oral solution (syrup/drops)
Pharmacological class Second-generation H₁-receptor antagonist
Common use Relief from allergic discomfort
Origin Synthetic

The Identity and Classification of Okacet

Okacet is a widely recognized synthetic medicinal product that delivers its effect via the active ingredient Cetirizine Hydrochloride. It is scientifically classified as a second-generation antihistamine and a selective H1-receptor antagonist. This classification is clinically recognized for providing effective symptomatic relief by blocking the specific receptors that histamine—a chemical released during allergic reactions—would normally activate.


This medicine is the primary metabolite of the older antihistamine hydroxyzine, distinguishing itself by being generally non-sedating at standard amounts due to its limited distribution into the central nervous system. As a piperazine derivative, Okacet is often available over-the-counter (OTC) in certain forms and regions, reinforcing its role as an accessible solution for acute allergic episodes.

Composition and Available Forms

The therapeutic effect of Okacet is derived from its single-ingredient product formulation, relying solely on Cetirizine Hydrochloride. This formulation is prepared for oral administration and is available in two main dosage forms: a solid tablet and a liquid oral solution, often sold as a syrup or drops. The liquid formulation is specifically positioned to offer a convenient solution for pediatric patients and others who may have difficulty swallowing the tablet, a key feature in its market differentiation.


The general purpose of Okacet is to provide alleviation of discomfort and symptoms associated with common allergic conditions, such as during a seasonal peak in pollen. It achieves this by performing selective peripheral H1-receptor blockade, interrupting the chain reaction that causes allergic responses. This interruption successfully helps control the body's undesirable reaction to environmental triggers, ensuring its primary benefit is delivered with a reduced potential for affecting central nervous system function.

Regulatory References

  1. MedlinePlus Drug Information on Cetirizine

What side effects are possible with Okacet?

Possible Side Effects and Safety Information

Regulatory documents classify the possible side effects of Okacet (Cetirizine Hydrochloride) based on their frequency of occurrence, primarily affecting the nervous and gastro-intestinal systems.

Official Frequency Classifications

Frequency Examples of Officially Listed Effects
Common (Up to 1 in 10) Somnolence (drowsiness), Fatigue, Dry mouth, Headache, Dizziness, Nausea.
Uncommon (Up to 1 in 100) Agitation, Diarrhoea, Pruritus (itching), Rash.
Rare (Up to 1 in 1,000) Hypersensitivity, Insomnia, Convulsions, Tachycardia, Abnormal hepatic function (reversible upon cessation).
Very Rare (Up to 1 in 10,000) Anaphylactic shock, Angioneurotic oedema (swelling), Syncope, Thrombocytopenia, Urinary retention.

Serious Adverse Reactions and Safety Notes

The most serious, albeit very rare, reactions officially documented include anaphylactic shock and angioneurotic oedema (severe allergic swelling). Abnormal liver function, characterized by elevated enzymes, is also listed as a rare event.

Regulatory labels include specific limitations regarding patient populations. Dose adjustment is required for individuals with renal impairment, and caution is advised for older adults due to increased sensitivity to adverse effects. The drug is contraindicated in end-stage renal disease requiring dialysis.

Furthermore, official documentation notes that some individuals may report severe pruritus or urticaria upon stopping the treatment, an observation recorded particularly after prolonged use. Caution is also necessary in patients with predisposition factors for urinary retention and before conducting allergy skin testing.

Overdose and Emergency Response

Overdose Manifestations

Overdose with Cetirizine Hydrochloride is primarily associated with central nervous system (CNS) effects. The most frequently documented manifestation in regulatory information is profound drowsiness or somnolence. Other officially documented signs include restlessness, irritability, confusion, and headache. In certain documented cases, particularly in infants, initial symptoms of restlessness and irritability have been noted, which later progress to excessive drowsiness. Cardiovascular effects, such as tachycardia (fast heart rate), have also been reported in some severe overdose scenarios.

When to Seek Urgent Medical Help

Government regulatory guidance explicitly mandates specific actions in the event of suspected overdose. Individuals must seek immediate medical attention and contact a Poison Control Center. Urgent medical help is required, and one must immediately call emergency services (such as 911 or equivalent) if the overdose is accompanied by severe, potentially life-threatening manifestations. These triggers include having a seizure, experiencing significant trouble breathing, or being unable to be awakened (loss of consciousness).

Overdose Management

There is no known specific antidote for Cetirizine Hydrochloride overdose documented in official prescribing information. Consequently, management must be symptomatic and supportive. Regulatory documents also note that the drug is not effectively removed by dialysis, a finding that limits procedural intervention options in the overdose context.

Therapeutic Uses of Okacet

The core therapeutic utility of Okacet, which contains the active ingredient cetirizine, is to provide symptomatic relief in situations involving heightened physiological activity caused by allergic responses. Okacet is commonly used to help manage symptoms associated with both seasonal and year-round allergies and skin conditions, and is relevant when supportive symptom management is appropriate.


What Okacet Treats: Main Uses and Benefits

Okacet is applied across domains where additional symptomatic support is needed. It is used for managing symptom clusters that may become intense or disruptive, such as those found in seasonal allergic rhinitis, perennial allergic rhinitis, and chronic urticaria (hives).

“It provides supportive relief that helps with easing the overall symptom load during periods of heightened symptoms.”

It is often used during phases when symptoms become more noticeable. Okacet provides supportive relief that contributes to improved day-to-day comfort by easing issues like sneezing, runny nose, itchy eyes, and pruritus (itching) from hives.


Quick Fact: Addressing Symptomatic Itching

Okacet is considered relevant for use in conditions where pruritus (itching) from allergic reactions, such as hives or chronic rash, creates noticeable interference with daily comfort.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility and Contraindications for Okacet Use

Official regulatory labeling establishes clear population eligibility rules for Okacet (Cetirizine Hydrochloride), defining who is permitted to use the medicine and who is strictly excluded.


Absolute Contraindications

Use is absolutely contraindicated in patients with a known hypersensitivity to the active ingredient, any excipients, its precursor hydroxyzine, or any related piperazine derivatives. Additionally, the medicine is contraindicated for patients with severe renal impairment defined by a creatinine clearance of less than 10 mL/min, as stated in the Summary of Product Characteristics (SmPC) and FDA labeling.


Age and Organ Function Restrictions

Eligibility rules vary by age and organ function:

  • Pediatric Use: The minimum eligible age is generally 6 months to 2 years for liquid formulations, depending on the indication, and 6 years for tablets. Use is not established in infants under 6 months.
  • Renal Impairment: Patients with moderate to severe renal impairment (creatinine clearance le 50 mL/min) require conditional use and a dose adjustment to maintain eligibility.
  • Older Adults (Geriatric): Use is permitted, but caution is necessary due to the higher likelihood of age-related decline in renal function.

Physiological Status Limitations

Use is not recommended for breastfeeding women because the active substance is known to pass into human milk. Conditional use is required for pregnant women, and patients with conditions predisposing them to urinary retention or those at risk of convulsions should proceed with caution only if recommended by a healthcare professional.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Okacet

Category Official Regulatory Statement
Medicinal product categories with documented interactions Central Nervous System (CNS) depressants; Alcohol; Food.
Specific interacting medicines (if explicitly listed) Theophylline (at a 400 mg/day dose).
Mechanistic basis of interactions Pharmacodynamic interaction (additive CNS impairment); Pharmacokinetic interaction (decreased clearance; altered absorption kinetics).
Population-specific interaction notes Formal prohibition for patients with end-stage renal disease requiring dialysis. Caution noted for individuals with predisposition factors for urinary retention.
Interaction-related restrictions Co-administration with alcohol or CNS depressants carries the risk of additional impairment of performance and alertness.

Interaction Classifications (High-Level)

Category Classification / Official Statement
Interaction severity classification Formal Contraindication for end-stage renal disease. Caution/Warning for CNS depressants.
Interaction-context constraints The total absorption (AUC) is unchanged by food, but the rate of absorption (Tmax) is delayed.

Resulting Interaction Structure

Official prescribing information confirms a primary pharmacodynamic interaction involving alcohol and other CNS depressants, which may lead to an additive impairment of mental alertness. A pharmacokinetic interaction is documented with Theophylline (400 mg daily dose), showing a small decrease in the clearance of Okacet, though it is not clinically significant at this level. No mandatory timing separation rules are documented. Critically, regulatory documents identify a formal contraindication for the medicine's use in patients with end-stage renal disease due to the high risk of drug accumulation. Studies showed no clinically significant pharmacokinetic interactions with agents like Erythromycin or Ketoconazole.

Mechanism of Action

How Okacet Works

Okacet’s mechanism of action is characterized by a targeted interference with specific biological signaling pathways. The primary action involves the active component, cetirizine, functioning as a selective inverse agonist/antagonist of the peripheral H1-histamine receptors.

Blockade of Peripheral H1-Histamine Receptors

This core mechanistic domain focuses on the binding of cetirizine to the H1 receptors found predominantly in peripheral tissues. By stabilizing these receptors in an inactive conformation, the drug prevents the natural signaling molecule histamine from binding and initiating its cascade. This action limits the histamine-driven increase in capillary permeability and nerve activation, which results in changes to the state of capillary permeability and nerve activation.

Modulation of Inflammatory Cell Movement

This secondary domain addresses the drug’s influence on the broader inflammatory response pathway. The mechanism extends beyond simple receptor blockage by also affecting the adherence and migration of specific immune cells, such as eosinophils, into responsive tissues. By dampening the movement of these cells, the drug modulates the signaling that supports cellular responses, influencing the local tissue signaling dynamics and determining the resulting observable physiological consequences.

Dosage and Administration Information

How to Use Okacet

Okacet (Cetirizine Hydrochloride) is officially administered via the oral route for general use, available in both tablet and oral solution forms. The medicine can also be utilized through intravenous and ophthalmic routes, as approved for specific formulations and clinical scenarios. The key principle governing its use is a standardized once-daily dosing regimen, which is independent of food intake.

Standard Dosing Principles

The standard oral dose for adults and adolescents (aged 12 years and older) is 10 mg once daily. For some patients, a lower dose of 5 mg once daily is recognized for the management of less severe symptoms. The maximum dose for oral administration is 10 mg per 24 hours.

Administration may be either short-term for acute allergic episodes or long-term when managing chronic conditions like perennial allergic rhinitis or chronic urticaria, according to established protocols.

Population-Specific Adjustments

Established guidelines mandate dose adjustment for certain patient groups. Individuals aged 12 years and older with moderate to severe renal impairment require a reduction of the oral dose to 5 mg once daily or 5 mg once every two days, depending on the degree of impairment.

For pediatric patients aged 6 to 11 years, the labeled dose is typically between 5 mg and 10 mg daily. For children aged 2 to 5 years, the starting dose is 2.5 mg once daily, with a maximum daily intake of 5 mg, which may be administered as a single or divided dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Okacet (Cetirizine)


The following summary describes the type of clinical research conducted for the active ingredient in Okacet (Cetirizine) and what the findings generally suggest, based on official regulatory and scientific reviews. This text focuses on the research landscape only and is not intended as medical advice or treatment guidance.

Evidence for Use in Seasonal and Perennial Allergies

The research base that explored the active ingredient in Okacet for both seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) consists of numerous short-term Randomized Controlled Trials (RCTs) and supporting systematic reviews. These studies were used in research exploring how symptoms change over time and were applied in studies examining patient-reported experiences. Studies focused on populations that included adults, adolescents, and children diagnosed with these conditions.

Researchers monitored Total Symptom Scores (TSS), which reflect outcomes related to physical discomfort such as sneezing, runny nose, and itching, as well as outcomes reflecting daily functioning. Studies reported measurements of symptom score changes, documenting the patterns observed when comparing the active ingredient against an inactive placebo or other active compounds.

While studies indicate patterns of consistency in measuring short-term symptom changes, there is limited information for long-term outcomes related to sustained use over multiple seasons or years, with research focusing mainly on intermediate-term safety tracking.


Research Landscape for Chronic Hives (Urticaria)

Okacet's active ingredient was studied for chronic urticaria, or hives, which is a condition characterized by fluctuating or episodic manifestations of intense itching and swelling. The evidence was derived from controlled trials and systematic reviews, primarily involving adult populations.

These studies monitored outcomes related to functional imbalance by using standardized activity scores, which combined objective measures like wheal count with a patient-reported outcome describing perceived discomfort from itching. Findings describe patterns observed in the studies related to the measured change in the intensity and duration of these outcomes.


What the Research Indicates is Still Uncertain

Key research limitation frames include follow-up durations were limited in many pivotal trials, especially concerning the durability of response over many years. Comparative evidence is limited regarding direct comparison with every other second-generation antihistamine. Furthermore, for conditions like Atopic Dermatitis, the evidence quality varies across studies, and findings were mixed for overall disease severity outcomes beyond measured changes in pruritus scores. Study results reflect the specific conditions under which they were conducted and describe group patterns, not personal outcomes.

Key Studies & References

  1. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit

Frequently Asked Questions (FAQ)

Common questions about Okacet (FAQ)

Q: How quickly can I expect Okacet to start working?

According to official product information, the active ingredient in Okacet generally begins to take effect within 30 minutes after being taken by mouth. The quick onset of action supports its use for acute allergic symptoms.


Q: How long does the effect of one dose of Okacet last?

Studies and official documents indicate that the antihistamine effect of a single dose of the active ingredient persists for at least 24 hours. This duration supports the standard once-daily dosing regimen described in the regulatory labeling.


Q: Are there any dietary restrictions or foods to avoid when taking Okacet?

Regulatory information states that there are no mandatory dietary restrictions, as food does not affect the total amount of the drug absorbed by the body. However, taking the medicine with food may delay the time it takes to reach peak concentration in the bloodstream by approximately 1.7 hours.


Q: Can Okacet be taken with other cold and flu medicines?

Okacet is to be used with caution if combined with other medicines classified as tranquilizers or sedatives, as this combination may increase the risk of drowsiness. Since many cold and flu medicines contain these types of ingredients, official documents note the importance of reviewing the ingredients of all combined medicines.


Q: Does taking Okacet before bed affect its effectiveness for daytime symptoms?

The drug is approved for a standardized once-daily dose, and the active ingredient provides 24-hour symptom relief regardless of the time it is taken. Since drowsiness is listed as a potential side effect, some individuals may choose to take their dose at night.


Q: Can Okacet be taken while driving or operating machinery?

Regulatory labeling includes a specific warning that caution is necessary when driving a car or operating potentially dangerous machinery because drowsiness is a potential effect. This risk of impairment is increased when the drug is taken concurrently with alcohol or other Central Nervous System (CNS) depressants.


Q: Is Okacet a type of steroid medication?

No, Okacet is not a steroid medication. It is scientifically classified in regulatory documents as a second-generation H1-receptor antagonist, which is a type of antihistamine.


Q: What is the general safety classification of Okacet in pregnancy (non-directive)?

Official labeling states that a health professional should be consulted before using this drug if a patient is pregnant. Furthermore, use is not recommended for women who are breastfeeding because the active substance passes into human milk.


Q: Is Okacet known to interact with blood pressure medications?

Official labeling does not specifically list blood pressure medications as interacting agents. Caution is advised when taking Okacet with any medication that increases drowsiness or has Central Nervous System (CNS) effects, as this combination may increase the risk of side effects.


Q: Why do some people say they take Okacet for sinus congestion?

Okacet is officially indicated for the relief of allergic symptoms such as runny nose, sneezing, and itchy eyes or throat, which are commonly associated with upper respiratory allergies. The term 'sinus congestion' itself is not typically used as a primary indication in the regulatory labeling.


Q: Can Okacet interact with herbal supplements like St. John's Wort?

Official cautions advise careful use with other medicines or supplements that can cause sleepiness, dry mouth, or difficulty urinating, as this may worsen side effects. Regulatory documents state that use with herbal supplements should be reviewed by a health professional.


Q: Is Okacet safe for people with heart conditions?

Studies on the active ingredient have indicated a negligible risk of specific cardiac effects in healthy subjects at standard amounts. Official labels note that a health professional should be consulted to review use if any underlying medical conditions exist.


Q: Does Okacet typically cause weight gain or loss?

Some postmarketing studies have associated weight gain with the long-term use of the active ingredient, potentially due to the drug's effect on appetite regulation. Weight changes are not always listed as a common side effect in primary regulatory labels.


Q: Are there any long-term safety concerns associated with Okacet use?

The most notable safety observation related to long-term use in regulatory documents is the potential for severe itching (pruritus) or hives (urticaria) to occur upon suddenly stopping the treatment after prolonged daily administration.


Q: Do official sources mention using Okacet for skin itching that isn't due to allergies?

The drug is primarily indicated for allergic conditions like chronic hives, which involve itching. Studies have examined the drug for its ability to reduce itching scores in other skin conditions, such as Atopic Dermatitis, though it is not a primary indication.


Q: Do the effects of Okacet wear off over time if you take it regularly?

Regulatory documents note that clinical research has limited information regarding the durability of the response over many years of sustained use. However, the active ingredient does not generally accumulate in the body with chronic administration.


Q: What should a patient do if they feel an unusual side effect while taking Okacet?

Official labeling states that use should be stopped and a health professional contacted if an unusual or unexpected reaction is experienced. If the reaction is severe or resembles a serious allergic reaction, regulatory guidance states that immediate medical help is warranted.

How should Okacet be stored and disposed of?

How to Store and Dispose of Okacet?

This section outlines the official, regulatory requirements for the storage, handling, and disposal of Okacet (Cetirizine Hydrochloride), as stated in governmental labeling.

Official Storage Requirements

Requirement Regulatory Statement
Temperature Store at Controlled Room Temperature, typically 20^circ to 25 C (68^circ to 77 F), or below 30 C (FDA, EMA).
Protection Keep in a tight or well-closed container and protect from light and moisture (USP, FDA).
Child Safety Keep this medicine out of the sight and reach of children (Mandatory Labeling).
Stability Do not use after the expiry date. The oral solution has a shelf-life of 6 months after opening (EMA SmPC).

Official Disposal Instructions

Official instructions mandate that patients do not throw away unused or expired Okacet via household waste or wastewater. Consult a pharmacist for guidance on appropriate pharmaceutical disposal methods, as these measures help to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Okacet found in:

A-Z Index: